News
In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...
Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s Wegovy in the first head-to-head study of the rival medicines. Zepbound won on ...
GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...
Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s ...
Losing weight with PCOS is challenging, but not impossible. While you can't spot-reduce belly fat, losing overall body fat can help shrink your midsection and reduce health risks. There's no ...
While you can't target belly fat alone spot reduction isn't scientifically supported, regular cycling especially when combined with a healthy diet helps burn more calories than you consume ...
Dr Indramani Upadhyay, MPT (Ortho), HOD, The Center for Knee and Hip Care, Vaishali, Ghaziabad shared how cycling specifically can help benefit belly fat reduction. Dr Indramani highlighted that ...
The most effective belly fat reduction strategy begins not with exercise but with strategic morning hydration. After 7-8 hours without fluid intake during sleep, your body experiences mild ...
Here's what else you can do. Karishma Yadav has shared a workout video targetting belly fat reduction. (Instagram/ Karishma Yadav) Losing stubborn belly fat takes time and effort, so be patient ...
Medical professionals suggest there are sustainable ways to shed belly fat. Combined with regular physical activity, thermogenic foods can help you in reducing belly fat without resorting to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results